Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/151121
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Romaguera, Rafael | - |
dc.contributor.author | Gómez Hospital, Joan Antoni | - |
dc.contributor.author | Sánchez Elvira, Guillermo | - |
dc.contributor.author | Gómez Lara, Josep | - |
dc.contributor.author | Ferreiro, José Luis | - |
dc.contributor.author | Roura, Gerard | - |
dc.contributor.author | Gracida Blancas, Montserrat | - |
dc.contributor.author | Homs, Silvia | - |
dc.contributor.author | Teruel, Luís M. | - |
dc.contributor.author | Cequier Fillat, Àngel R. | - |
dc.date.accessioned | 2020-02-25T09:01:28Z | - |
dc.date.available | 2020-02-25T09:01:28Z | - |
dc.date.issued | 2013-02-18 | - |
dc.identifier.issn | 0896-4327 | - |
dc.identifier.uri | http://hdl.handle.net/2445/151121 | - |
dc.description.abstract | Objectives: To assess the usefulness of the MGuard stent in patients with ST‐segment elevation myocardial infarction (STEMI) in whom a high thrombus burden persists after manual aspiration. Background: In some patients with STEMI, a high thrombus burden may persist after manual aspiration. These patients may be at high risk of distal embolization and therefore impaired myocardial reperfusion. The MGuard is a novel mesh‐covered stent designed to minimize thrombus embolization. Methods: Single‐arm, prospective registry of patients with STEMI and high thrombus burden after aggressive thrombus aspiration treated with the MGuard stent. High thrombus burden was defined as thrombus burden grade 4 or 5 according to the TIMI score. Lesions with a side branch ≥2 mm and patients with cardiogenic shock were not included. The study end‐points were proportion of final TIMI 3 flow, normal myocardial blush, and complete ST‐segment resolution. Results: Fifty‐six patients were included. After MGuard stent implantation >85% of cases had thrombus score = 0. Final TIMI 3 flow was achieved in 82% of cases, normal myocardial blush in 55%, and complete ST‐segment resolution in 59%. Occlusion of a side branch (<2 mm) occurred in 2 cases (3.5%), embolization to a distal branch in 5 cases (8.9%), and transient no‐reflow in 4 cases (7.1%). Major adverse cardiac events rate at 9 months was 3.6%, including 1 definite acute stent thrombosis and 1 target‐vessel revascularization. Conclusions: The MGuard stent may be useful to prevent distal embolization in patients with STEMI and high thrombus burden despite mechanical aspiration. | - |
dc.format.extent | 7 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wiley Hindawi Publishing | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1111/j.1540-8183.2013.12011.x | - |
dc.relation.ispartof | Journal of Interventional Cardiology, 2013, vol. 26, num. 1, p. 1-7 | - |
dc.relation.uri | https://doi.org/10.1111/j.1540-8183.2013.12011.x | - |
dc.rights | cc-by (c) Romaguera, Rafael et al., 2013 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Infart de miocardi | - |
dc.subject.classification | Pròtesis de Stent | - |
dc.subject.other | Myocardial infarction | - |
dc.subject.other | Stents (Surgery) | - |
dc.title | MGuard mesh-covered stent for treatment of ST-segment elevation myocardial infarction with high thrombus burden despite manual aspiration | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 633061 | - |
dc.date.updated | 2020-02-25T09:01:28Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
633061.pdf | 185.54 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License